January 10, 2022 Experience Convey Health Solutions acquisition of HealthSmart International We are advising Convey Health Solutions on the transaction
December 20, 2021 Experience Dynamics Special Purpose $601 million combination with Senti Biosciences We are advising Dynamics, a SPAC, on the transaction
November 18, 2021 Experience Novo Nordisk $3.3 billion acquisition of Dicerna Pharmaceuticals We are advising Novo Nordisk on the transaction
November 16, 2021 Experience BDT Capital Partners acquires a majority interest in MJH Life Sciences We are advising BDT Capital Partners on the transaction
August 24, 2021 Experience Triple-S Management $900 million acquisition by GuideWell We are advising Triple-S on the transaction
August 11, 2021 Experience Adagio Therapeutics $356 million IPO We advised the underwriters on the IPO and Nasdaq listing
August 3, 2021 Experience RxSight $117.6 million IPO We advised the underwriters in connection with the IPO and Nasdaq listing
August 3, 2021 Experience Tenaya Therapeutics $207 million IPO We advised the underwriters on the IPO and Nasdaq listing
July 27, 2021 Experience SOPHiA GENETICS $234 million IPO and $20 million private placement We advised SOPHiA GENETICS on its IPO, Nasdaq listing and concurrent private placement
July 22, 2021 Experience TScan Therapeutics $100 million IPO We advised the underwriters on the IPO and Nasdaq listing